Healthcare provider profile · identity verified

John B Ebens, MD

Internal Medicine · GREELEY, CO · NPI 1649257544

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	714	194
Levothyroxine Sodium	Levothyroxine Sodium	679	177
Lisinopril	Lisinopril	554	158
Amlodipine Besylate	Amlodipine Besylate	482	129
Omeprazole	Omeprazole	399	112
Losartan Potassium	Losartan Potassium	367	98
Simvastatin	Simvastatin	338	92
Gabapentin	Gabapentin	309	80
Metformin Hcl	Metformin Hcl	282	82
Metoprolol Succinate	Metoprolol Succinate	273	74
Hydrochlorothiazide	Hydrochlorothiazide	242	65
Rosuvastatin Calcium	Rosuvastatin Calcium	228	67
Pantoprazole Sodium	Pantoprazole Sodium	187	57
Furosemide	Furosemide	175	48
Tamsulosin Hcl	Tamsulosin Hcl	170	54
Eliquis	Apixaban	163	39
Duloxetine Hcl	Duloxetine Hcl	162	37
Sertraline Hcl	Sertraline Hcl	159	43
Tramadol Hcl	Tramadol Hcl	148	35
Trazodone Hcl	Trazodone Hcl	141	44
Metoprolol Tartrate	Metoprolol Tartrate	140	44
Allopurinol	Allopurinol	137	36
Potassium Chloride	Potassium Chloride	135	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	28
Pravastatin Sodium	Pravastatin Sodium	120	32
Escitalopram Oxalate	Escitalopram Oxalate	116	33
Glimepiride	Glimepiride	109	30
Synthroid	Levothyroxine Sodium	108	30
Lorazepam	Lorazepam	104	20
Metformin Hcl Er	Metformin Hcl	100	26
Warfarin Sodium	Warfarin Sodium	97	26
Meloxicam	Meloxicam	93	23
Spironolactone	Spironolactone	93	27
Oxycodone Hcl	Oxycodone Hcl	91	13
Montelukast Sodium	Montelukast Sodium	90	27
Zolpidem Tartrate	Zolpidem Tartrate	89	22
Carvedilol	Carvedilol	85	24
Finasteride	Finasteride	79	19
Alprazolam	Alprazolam	74	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	71	19
Citalopram Hbr	Citalopram Hydrobromide	70	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	22
Albuterol Sulfate Hfa	Albuterol Sulfate	68	30
Venlafaxine Hcl Er	Venlafaxine Hcl	66	18
Atenolol	Atenolol	63	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	18
Tizanidine Hcl	Tizanidine Hcl	60	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	suppressed
Famotidine	Famotidine	57	13
Prednisone	Prednisone	55	25
Clopidogrel	Clopidogrel Bisulfate	50	15
Clonidine Hcl	Clonidine Hcl	48	14
Lamotrigine	Lamotrigine	42	suppressed
Clonazepam	Clonazepam	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	14
Oxybutynin Chloride Er	Oxybutynin Chloride	40	suppressed
Baclofen	Baclofen	39	suppressed
Lansoprazole	Lansoprazole	39	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Ezetimibe	Ezetimibe	35	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	20
Propranolol Hcl	Propranolol Hcl	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Xarelto	Rivaroxaban	33	suppressed
Diazepam	Diazepam	32	13
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Myrbetriq	Mirabegron	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Azithromycin	Azithromycin	26	19
Triamcinolone Acetonide	Triamcinolone Acetonide	26	12
Celecoxib	Celecoxib	25	suppressed
Gemfibrozil	Gemfibrozil	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Ozempic	Semaglutide	25	suppressed
Estradiol	Estradiol	24	suppressed
Pregabalin	Pregabalin	23	11
Terazosin Hcl	Terazosin Hcl	23	suppressed
Nitroglycerin	Nitroglycerin	22	11
Donepezil Hcl	Donepezil Hcl	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Ramipril	Ramipril	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	18
Clotrimazole	Clotrimazole	20	suppressed
Digoxin	Digoxin	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	18
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Naproxen	Naproxen	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Fosinopril Sodium	Fosinopril Sodium	17	suppressed
Glipizide	Glipizide	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Temazepam	Temazepam	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Levemir	Insulin Detemir	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nystatin	Nystatin	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error